Kotulak-Chrzaszcz et al. had shown that SMO, Gli1, and Shh could promote progression of cervical cancer, but no drugs targeting SMO, Gli1, and Shh were approved for prevention and therapy of cervical cancer [30]. Here, SHH is linked to cervical carcinoma.